NinePointTwo Capital
- SEC CIK
- 0001824516
- Latest filing
- Feb 14, 2024
IMGN holding history
ImmunoGen, Inc. in every 13F filed by NinePointTwo Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IMGN overviewAll 13F holders of IMGNFull Q4 2023 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −17,767−100.0% | Sold out | Holders |
| Q3 2023 | 17,767 | $281.0K | 0.1% | +17,767 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −37,533−100.0% | Sold out | Holders |
| Q4 2022 | 37,533 | $186.0K | 0.1% | +37,533 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −87,502−100.0% | Sold out | Holders |
| Q1 2022 | 87,502 | $416.0K | 0.1% | +87,502 | New | Holders |